Yüklüyor......
Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
Current treatments for Alzheimer’s disease (AD) attenuate the progression of symptoms and aim to improve the patient’s quality of life. Licensed medicines are mostly for oral administration and are limited by the difficulty in crossing the blood–brain barrier (BBB). Here in, the nasal route has been...
Kaydedildi:
| Yayımlandı: | Int J Nanomedicine |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8256381/ https://ncbi.nlm.nih.gov/pubmed/34234432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S305851 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|